PI specialist ITIC targets Hong Kong and Singapore for regional expansion
May 11 2023 by Marcus Alcock-
Expanding into non-ILS capital pools is a priority: MS Amlin
- November 4
William Ho, MS Amlin Asia Pacific CEO, discusses the evolving regional reinsurance landscape, the impact of recent cat losses, and the reinsurer’s strategic growth plans in APAC.
-
Steadfast on track to complete US$200m in acquisitions in FY 2025
- November 4
In its annual general meeting, the Australian broking group addressed allegations of opacity in its strata operations and leadership succession.
-
Specialty growth, Australia, Dubai operations fire up Markel’s APAC growth
- November 1
The Lloyd’s player, set to grow premiums by 40% in 2024, is seeing strong demand for the war, renewable energy, and casualty classes in the region, says Christian Stobbs.
-
India and Korea bright spots in FM’s regional play
- October 31
Growing Asian economies drive demand for data-driven risk mitigation, say the mutual's regional leaders James Thompson and Tan Hian Hong.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | The hunt for diversification and performance revitalizes appetite for Asian currency bonds
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.